From: Fibroblast growth factor receptor fusions in cancer: opportunities and challenges
Gene | 5′-Gene | 3′-Gene | Tumor type | Case reported |
---|---|---|---|---|
FGFR1 | ZNF198 | FGFR1 | Hematopoietic neoplasm | Not reported |
BCR | FGFR1 | Hematopoietic neoplasm | Not reported | |
FOP1 | FGFR1 | Hematopoietic neoplasm | Not reported | |
CNTRL | FGFR1 | Hematopoietic neoplasm | Not reported | |
BAG4 | FGFR1 | Non-small cell lung cancer | 1/220 | |
RHOT1 | FGFR1 | Breast cancer | 1/1019 | |
NSD3 | FGFR1 | Breast cancer | 2/1019 | |
FGFR1 | HOOK3 | Gastrointestinal stromal tumor | 1/186 | |
FGFR1 | TACC1 | Glioblastoma | 1/97 | |
FGFR1 | ZNF703 | Breast cancer | 1/24 | |
FGFR1 | NTM | Bladder urothelial carcinoma | 1/295 | |
FGFR1 | ADAM18 | Breast cancer | 1/1019 | |
FGFR1 | SLC20A2 | Lung adenocarcinoma | 1/487 | |
FGFR2 | FGFR2 | PPHLN1 | Intrahepatic cholangiocarcinoma | 20/122 |
FGFR2 | BICC1 | Intrahepatic cholangiocarcinoma | 2/66 | |
FGFR2 | AHCYL | Intrahepatic cholangiocarcinoma | 7/66 | |
FGFR2 | CCAR2 | Lung squamous cell carcinoma | 1/220 | |
FGFR2 | USP10 | Ovarian cancer | 1/400 | |
FGFR2 | OFD1 | Thyroid carcinoma | 1/494 | |
FGFR3 | FGFR3 | TACC3 | Glioblastoma | 6/158 |
FGFR3 | TACC3 | Low-grade glioma | 1/266 | |
FGFR3 | TACC3 | Non-small cell lung cancer | 5/220 | |
FGFR3 | TACC3 | Bladder cancer | 3/121 | |
FGFR3 | TACC3 | Head and neck squamous cancer | 2/300 | |
FGFR3 | TACC3 | Lung squamous cell carcinoma | 4/2375 | |
FGFR3 | BAIAP2L1 | Bladder cancer | 2/46 | |
FGFR3 | TPRG1 | Head and neck squamous cancer | 1/300 | |
FGFR3 | ELAVL3 | Low-grade glioma | 1/266 | |
FGFR3 | AES | Prostate adenocarcinoma | 1/178 |